Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Priya Sumithran
Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
Drug Safety
Toxicology
Pharmacology
Combination Phentermine and Topiramate for Weight Maintenance: The First Australian Experience
Medical Journal of Australia
Medicine
Related publications
Drugs in the Treatment of Obesity: Sibutramine, Orlistat and Rimonabant
Public Health Nutrition
Nutrition
Dietetics
Public Health
Environmental
Medicine
Occupational Health
Risk‐Benefit Assessment of Foods
EFSA Journal
Veterinary
Microbiology
Food Science
Animal Science
Parasitology
Plant Science
Zoology
Benefit–risk Assessment of Vitamin D Supplementation
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Weight Reduction and Long-Term Maintenance After 18 Months Treatment With Orlistat for Obesity
International Journal of Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
The Application of the Ahp Risk-Benefit Assessment in Certification of Organic Farming
Modern Management Review
Benefit Risk Assessment and Update on the Use of Docetaxel in the Management of Breast Cancer
Cancer Management and Research
Oncology
Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment
Cell Stem Cell
Molecular Medicine
Genetics
Cell Biology
A Unified Framework for Classification of Methods for Benefit-Risk Assessment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Crystal Structure of Pathogenic Staphylococcus Aureus Lipase Complex With the Anti-Obesity Drug Orlistat
Scientific Reports
Multidisciplinary
